RHONE MA HOLDINGS BERHAD

KLSE: 5278 (RHONEMA)

Kemas kini terakhir: 4 hari lalu, 1:36PM

0.635

0.00 (0.00%)

Penutupan Terdahulu 0.635
Buka 0.635
Purata Dagangan (3B) 27,434
Modal Pasaran 140,478,512
Harga / Pendapatan (P/E TTM) 15.88
Harga / Jualan (P/S) 0.910
Harga / Buku (P/B) 0.840
Julat 52 Minggu
0.580 (-8%) — 0.800 (25%)
Hasil Dividen (DY TTM) 3.94%
Margin Keuntungan 5.81%
Margin Operasi (TTM) 10.34%
EPS Cair (TTM) 0.040
Pertumbuhan Hasil Suku Tahunan (YOY) -5.00%
Pertumbuhan Pendapatan Suku Tahunan (YOY) -5.80%
Jumlah Hutang/Ekuiti (D/E MRQ) 13.42%
Nisbah Semasa (MRQ) 5.27
Aliran Tunai Operasi (OCF TTM) 18.84 M
Aliran Tunai Bebas Leveraj (LFCF TTM) 13.85 M
Pulangan Atas Aset (ROA TTM) 5.59%
Pulangan Atas Ekuiti (ROE TTM) 7.43%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Drug Manufacturers - Specialty & Generic (MY) Bercampur Bercampur
Drug Manufacturers - Specialty & Generic (Global) Menurun Bercampur
Stok RHONEMA Bercampur Bercampur

AISkor Stockmoo

-0.2
Konsensus Penganalisis NA
Aktiviti Orang Dalam NA
Volatiliti Harga 2.5
Purata Bergerak Teknikal -2.5
Osilator Teknikal -0.5
Purata -0.17

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
RHONEMA 140 M 3.94% 15.88 0.840
KOTRA 593 M 6.38% 14.81 2.27
YSPSAH 305 M 5.12% 11.32 0.740
PLABS 83 M - 30.00 1.04
DPHARMA 1 B 2.48% 17.29 1.60

Rhone Ma Holdings Bhd is an investment holding company and are engaged in the provision of management services. It operates through its subsidiaries so it offers animal health services as well as the manufacturing and distribution of animal health products. The operating segments of the group are Animal health products and equipment , Food ingredients, and Others. Animal health products and equipment segment includes marketing, trading, distribution and manufacturing of animal health products and undertaking research and development activities related to animal health, food safety and agriculture in animal health products. The animal health products offered include vaccines, pharmaceuticals, and feed additives. It is also involved in the distribution and supply of food ingredients.

Sektor Healthcare
Industri Drug Manufacturers - Specialty & Generic
Gaya Pelaburan Small Value
% Dimiliki oleh Orang Dalam 86.01%
% Dimiliki oleh Institusi 1.36%

Tiada data dalam julat masa ini.

Tiada data dalam julat masa ini.

Tarikh Jenis Butiran
24 Apr 2025 Pengumuman Statement to Shareholders in relation to the Proposed Share Buy-Back Authority of up to 10% of the total number of issued shares of the Company
24 Apr 2025 Pengumuman Annual Report & CG Report - 2024
23 Apr 2025 Pengumuman General Meetings: Notice of Meeting
16 Apr 2025 Pengumuman RHONEMA - Notice of Book Closure
15 Apr 2025 Pengumuman Rhone Ma Holdings Berhad ("RMH" or 'the Company") - Proposed Share Buy-Back Authority
15 Apr 2025 Pengumuman Final Dividend
11 Apr 2025 Pengumuman DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Intention to Deal During Closed Period
07 Apr 2025 Pengumuman DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
07 Apr 2025 Pengumuman Changes in Director's Interest (Section 219 of CA 2016) - DR LIM BAN KEONG
07 Apr 2025 Pengumuman Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR LIM BAN KEONG
03 Apr 2025 TheEdge Cover Story: Fatter dividends declared in FY2024 ahead of 2% dividend tax
13 Mar 2025 Pengumuman Changes in Director's Interest (Section 219 of CA 2016) - DR LIM BAN KEONG
13 Mar 2025 Pengumuman DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
13 Mar 2025 Pengumuman Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - TEO KWEE HOCK
13 Mar 2025 Pengumuman Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR LIM BAN KEONG
12 Mar 2025 Pengumuman DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
12 Mar 2025 Pengumuman Changes in Director's Interest (Section 219 of CA 2016) - DR LIM BAN KEONG
12 Mar 2025 Pengumuman Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR LIM BAN KEONG
11 Mar 2025 Pengumuman DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
11 Mar 2025 Pengumuman Changes in Director's Interest (Section 219 of CA 2016) - DR LIM BAN KEONG
11 Mar 2025 Pengumuman Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR LIM BAN KEONG
07 Mar 2025 Pengumuman Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR LIM BAN KEONG
07 Mar 2025 Pengumuman Changes in Director's Interest (Section 219 of CA 2016) - DR LIM BAN KEONG
07 Mar 2025 Pengumuman DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
05 Mar 2025 Pengumuman Changes in Director's Interest (Section 219 of CA 2016) - DR LIM BAN KEONG
05 Mar 2025 Pengumuman Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR LIM BAN KEONG
05 Mar 2025 Pengumuman DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
04 Mar 2025 Pengumuman Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - MR FOONG KAM WENG
04 Mar 2025 Pengumuman Changes in Director's Interest (Section 219 of CA 2016) - MR FOONG KAM WENG
04 Mar 2025 Pengumuman DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
03 Mar 2025 Pengumuman Changes in Director's Interest (Section 219 of CA 2016) - DR LIM BAN KEONG
03 Mar 2025 Pengumuman Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR LIM BAN KEONG
03 Mar 2025 Pengumuman DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
21 Feb 2025 Pengumuman Changes in Director's Interest (Section 219 of CA 2016) - DR LIM BAN KEONG
21 Feb 2025 Pengumuman Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR LIM BAN KEONG
21 Feb 2025 Pengumuman DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
20 Feb 2025 Pengumuman DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
20 Feb 2025 Pengumuman Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR LIM BAN KEONG
20 Feb 2025 Pengumuman Changes in Director's Interest (Section 219 of CA 2016) - DR LIM BAN KEONG
19 Feb 2025 Pengumuman DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings During Closed Period
19 Feb 2025 Pengumuman Changes in Director's Interest (Section 219 of CA 2016) - DR LIM BAN KEONG
19 Feb 2025 Pengumuman Press Release: Rhone Ma Holdings Berhad Delivers Strong FYE2024 Performance, Recording RM211.6 Million in Revenue
19 Feb 2025 Pengumuman Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR LIM BAN KEONG
19 Feb 2025 Pengumuman Quarterly rpt on consolidated results for the financial period ended 31/12/2024
19 Feb 2025 Pengumuman Rhone Ma Holdings Berhad ("RMH" or "Company") - Extension of Time for the Utilisation of Proceeds raised from the Private Placement.
Papar semua
Hasil Dividen (DY TTM) 3.94%
Purata Hasil Dividen 5T 2.72%
Nisbah Pembayaran 61.27%
Jangkaan Pembayaran Dividen Seterusnya Nov 2025
Tarikh EX Tarikh Pengumuman Tarikh Pembayaran Perincian
25 Jun 2025 15 Apr 2025 14 Jul 2025 0.01 Tunai
13 Dec 2024 18 Nov 2024 27 Dec 2024 0.01 Tunai
22 Oct 2024 08 Oct 2024 04 Nov 2024 0.005 Tunai
27 Jun 2024 16 Apr 2024 15 Jul 2024 0.01 Tunai
05 Jan 2024 15 Dec 2023 02 Feb 2024 0.01 Tunai
28 Jun 2023 11 Apr 2023 17 Jul 2023 0.01 Tunai
30 Dec 2022 15 Dec 2022 16 Jan 2023 0.01 Tunai
01 Jul 2022 12 Apr 2022 15 Jul 2022 0.01 Tunai
12 Jan 2022 24 Dec 2021 25 Jan 2022 0.01 Tunai
01 Jul 2021 04 Jun 2021 15 Jul 2021 0.01 Tunai
02 Jul 2020 06 May 2020 15 Jul 2020 0.01 Tunai
02 Jul 2019 29 Apr 2019 15 Jul 2019 0.02 Tunai
29 Jan 2019 15 Jan 2019 13 Feb 2019 0.01 Tunai
Papar semua

Hasil Dividen Tahunan

Tahun Dividen Tahunan ($) Kekerapan/Tahun Hasil %
2025 0.010 1 1.58
2024 0.035 4 5.19
2023 0.020 2 2.90
2022 0.020 2 2.94
2021 0.010 1 1.35
2020 0.010 1 1.24
2019 0.030 2 4.51
Papar semua
0.6440.6440.6280.6280.6120.6120.5960.5960.5800.580Apr 16Apr 16Apr 17Apr 17Apr 18Apr 18Apr 21Apr 21Apr 22Apr 22Apr 23Apr 23Apr 24Apr 24Apr 25Apr 25

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

10010075755050252500RSI (14H)
0.0020.0020.0000.000-0.002-0.002-0.004-0.004-0.006-0.006MACD (12, 26, 9)

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2025 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda